<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK542336" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK542336/" /><meta name="ncbi_pagename" content="NFIA-Related Disorder - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>NFIA-Related Disorder - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="NFIA-Related Disorder" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/06/13" /><meta name="citation_author" content="T Niroshini Senaratne" /><meta name="citation_author" content="Fabiola Quintero-Rivera" /><meta name="citation_pmid" content="31194316" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK542336/" /><meta name="citation_keywords" content="NFIA Haploinsufficiency" /><meta name="citation_keywords" content="NFIA Haploinsufficiency" /><meta name="citation_keywords" content="Nuclear factor 1 A-type" /><meta name="citation_keywords" content="NFIA" /><meta name="citation_keywords" content="NFIA-Related Disorder" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="NFIA-Related Disorder" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="T Niroshini Senaratne" /><meta name="DC.Contributor" content="Fabiola Quintero-Rivera" /><meta name="DC.Date" content="2019/06/13" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK542336/" /><meta name="description" content="For the purposes of this chapter, NFIA-related disorder is defined as heterozygous inactivation or disruption of only NFIA without involvement of adjacent or surrounding genes. NFIA-related disorder comprises central nervous system abnormalities (most commonly abnormalities of the corpus callosum) with or without urinary tract defects, such as unilateral or bilateral vesicoureteral reflux and hydronephrosis. Additional features include macrocephaly, seizures, developmental delay and/or cognitive impairment, nonspecific dysmorphic features, ventriculomegaly, and hypotonia, which can exacerbate motor delay and feeding issues in infancy. Rarer features may include strabismus, cutis marmorata, or craniosynostosis of the metopic, lambdoid, or sagittal suture." /><meta name="og:title" content="NFIA-Related Disorder" /><meta name="og:type" content="book" /><meta name="og:description" content="For the purposes of this chapter, NFIA-related disorder is defined as heterozygous inactivation or disruption of only NFIA without involvement of adjacent or surrounding genes. NFIA-related disorder comprises central nervous system abnormalities (most commonly abnormalities of the corpus callosum) with or without urinary tract defects, such as unilateral or bilateral vesicoureteral reflux and hydronephrosis. Additional features include macrocephaly, seizures, developmental delay and/or cognitive impairment, nonspecific dysmorphic features, ventriculomegaly, and hypotonia, which can exacerbate motor delay and feeding issues in infancy. Rarer features may include strabismus, cutis marmorata, or craniosynostosis of the metopic, lambdoid, or sagittal suture." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK542336/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/nfia-dis/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK542336/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B3BEAE03F8BD1000000000764027F.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK542336_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK542336_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/norrie/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ngly1-cddg/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK542336_"><span class="title" itemprop="name"><i>NFIA</i>-Related Disorder</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: NFIA Haploinsufficiency</div><p class="contrib-group"><span itemprop="author">T Niroshini Senaratne</span>, PhD and <span itemprop="author">Fabiola Quintero-Rivera</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK542336_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK542336_ai__"><div class="contrib half_rhythm"><span itemprop="author">T Niroshini Senaratne</span>, PhD<div class="affiliation small">Pathology and Laboratory Medicine<br />Clinical Genomics Center<br />David Geffen School of Medicine<br />University of California, Los Angeles<br />Los Angeles, California<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.alcu.tendem@entaranest" class="oemail">ude.alcu.tendem@entaranest</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Fabiola Quintero-Rivera</span>, MD<div class="affiliation small">Associate Professor, Pathology and Laboratory Medicine<br />Clinical and Molecular Cytogenetics Laboratory<br />Clinical Genomics Center<br />University of California, Los Angeles<br />Los Angeles, California<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.alcu.tendem@oretniuqf" class="oemail">ude.alcu.tendem@oretniuqf</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 13, 2019</span>.</p><p><em>Estimated reading time: 17 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="nfia-dis.Summary" itemprop="description"><h2 id="_nfia-dis_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>For the purposes of this chapter, <i>NFIA</i>-related disorder is defined as <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> inactivation or disruption of only <i>NFIA</i> without involvement of adjacent or surrounding genes. <i>NFIA</i>-related disorder comprises central nervous system abnormalities (most commonly abnormalities of the corpus callosum) with or without urinary tract defects, such as unilateral or bilateral vesicoureteral reflux and hydronephrosis. Additional features include macrocephaly, seizures, developmental delay and/or cognitive impairment, nonspecific <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features, ventriculomegaly, and hypotonia, which can exacerbate motor delay and feeding issues in infancy. Rarer features may include strabismus, cutis marmorata, or craniosynostosis of the metopic, lambdoid, or sagittal suture.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>NFIA</i>-related disorder is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by detection of one of the following: a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> intragenic <i>NFIA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; a heterozygous <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of the 1p31.3 region that includes part or all of <i>NFIA</i> with surrounding genes intact; or a <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a>/other rearrangement with a 1p31.3 breakpoint that disrupts <i>NFIA.</i></p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Standard treatment of seizure disorder, tethered spinal cord, recurrent urinary tract infections, hydronephrosis, strabismus, craniosynostosis, and developmental delays.</p><p><i>Surveillance:</i> Affected individuals should be followed by the appropriate specialists (e.g., neurologist, urologist, and/or clinical geneticist) as needed based on their particular features.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>NFIA</i>-related disorder is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Each child of an individual with <i>NFIA</i>-related disorder has a 50% chance of inheriting the causative genetic alteration. The proportion of <i>NFIA</i>-related disorder caused by <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> variants is approximately 75%-80%. Prenatal diagnosis for a pregnancy at increased risk is possible if the causative genetic alteration in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member is known.</p></div></div><div id="nfia-dis.Diagnosis"><h2 id="_nfia-dis_Diagnosis_">Diagnosis</h2><p><i>NFIA</i>-related disorder is defined here as <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> inactivation or disruption of only <i>NFIA</i>; larger, nonrecurrent <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 1p32-p31 deletions are discussed in <a href="#nfia-dis.Genetically_Related_Allelic_Dis">Genetically Related Disorders</a>.</p><div id="nfia-dis.Suggestive_Findings"><h3>Suggestive Findings</h3><p>An <i>NFIA</i>-related disorder <b>should be suspected</b> in individuals with the following clinical and radiographic findings.</p><p><b>Clinical features</b></p><ul><li class="half_rhythm"><div>Macrocephaly</div></li><li class="half_rhythm"><div>Seizures including:</div><ul><li class="half_rhythm"><div>Generalized tonic-clonic</div></li><li class="half_rhythm"><div>Pseudo-seizures</div></li><li class="half_rhythm"><div>Nonspecific seizure disorders</div></li></ul></li><li class="half_rhythm"><div>Hypotonia (generalized/neonatal)</div></li><li class="half_rhythm"><div>Developmental delay</div></li><li class="half_rhythm"><div>Frequent urinary tract infections</div></li><li class="half_rhythm"><div>Nonspecific <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features (see <a href="#nfia-dis.Clinical_Characteristics">Clinical Characteristics</a>)</div></li><li class="half_rhythm"><div>Other, less common findings, including eye abnormalities (e.g., strabismus) or cutis marmorata</div></li></ul><p><b>Radiographic abnormalities</b></p><ul><li class="half_rhythm"><div><b>Brain</b></div><ul><li class="half_rhythm"><div>Abnormalities of the corpus callosum including agenesis or hypoplasia of the corpus callosum</div></li><li class="half_rhythm"><div>Ventriculomegaly (typically non-progressive)</div></li><li class="half_rhythm"><div>Hydrocephalus</div></li><li class="half_rhythm"><div>Less commonly, Chiari type I malformation and/or subarachnoid hemorrhage</div></li></ul></li><li class="half_rhythm"><div><b>Urinary tract</b></div><ul><li class="half_rhythm"><div>Vesicoureteral reflux</div></li><li class="half_rhythm"><div>Hydronephrosis</div></li><li class="half_rhythm"><div>Renal cysts</div></li></ul></li><li class="half_rhythm"><div><b>Spine.</b> Tethered spinal cord</div></li><li class="half_rhythm"><div><b>Skull.</b> Rarely, craniosynostosis, which may involve the metopic, lambdoid, or sagittal sutures</div></li></ul></div><div id="nfia-dis.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>NFIA</i>-related disorder (defined here as <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> inactivation or disruption of only <i>NFIA</i>) <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by detection of one of the following (see <a class="figpopup" href="/books/NBK542336/table/nfia-dis.T.molecular_genetic_testing_use/?report=objectonly" target="object" rid-figpopup="fignfiadisTmoleculargenetictestinguse" rid-ob="figobnfiadisTmoleculargenetictestinguse">Table 1</a>):</p><ul><li class="half_rhythm"><div>Heterozygous intragenic <i>NFIA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></div></li><li class="half_rhythm"><div>Heterozygous <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of the 1p31.3 region that includes part or all of <i>NFIA</i> with surrounding genes intact</div></li></ul><ul><li class="half_rhythm"><div>Chromosome <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> / other rearrangement with a 1p31.3 breakpoint that disrupts <i>NFIA</i></div></li></ul><p>Note: Molecular testing by CMA or karyotyping may detect a large and/or complex <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> rearrangement that inactivates <i>NFIA</i> and one or more (often adjacent) genes. Because individuals with such rearrangements (sometimes termed the <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 1p32-p31 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a>) have additional features, they are not the focus of this <i>GeneReview</i> and are described in <a href="#nfia-dis.Genetically_Related_Allelic_Dis">Genetically Related Disorders</a>.</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis (CMA)</b>, a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b><a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a></b> or <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm">If not already performed, <b>CMA</b> may be obtained to detect genome-wide deletions that include <i>NFIA</i>. The ability to determine the size of the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> depends on the type of microarray used, the density of the probes in the 1p31.3 region, and the size cutoff for reporting. The <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> size of the <i>NFIA</i> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> is 380 kb.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>NFIA</i> and other genes of interest (see <a href="#nfia-dis.Differential_Diagnosis">Differential Diagnosis</a>) may be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm">More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing (when available) including <b><a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a></b> and <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><p><b>Karyotype.</b> If clinical suspicion is high and other <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> methods have not identified a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> involving <i>NFIA</i>, a high-resolution <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> to detect a balanced chromosomal rearrangement involving the 1p31 region, followed by custom MLPA to confirm <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>NFIA</i>, or sequencing of the breakpoints to confirm disruption of <i>NFIA</i>, could be considered.</p><div id="nfia-dis.T.molecular_genetic_testing_use" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>NFIA</i>-Related Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK542336/table/nfia-dis.T.molecular_genetic_testing_use/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nfia-dis.T.molecular_genetic_testing_use_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_nfia-dis.T.molecular_genetic_testing_use_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_nfia-dis.T.molecular_genetic_testing_use_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_nfia-dis.T.molecular_genetic_testing_use_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_nfia-dis.T.molecular_genetic_testing_use_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>NFIA</i></td><td headers="hd_h_nfia-dis.T.molecular_genetic_testing_use_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_nfia-dis.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5/13&#x000a0;<sup>4,&#x000a0;5</sup></td></tr><tr><td headers="hd_h_nfia-dis.T.molecular_genetic_testing_use_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_nfia-dis.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnotes 7 &#x00026; 8</td></tr><tr><td headers="hd_h_nfia-dis.T.molecular_genetic_testing_use_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">CMA&#x000a0;<sup>9</sup></td><td headers="hd_h_nfia-dis.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5/13&#x000a0;<sup>5,&#x000a0;10</sup></td></tr><tr><td headers="hd_h_nfia-dis.T.molecular_genetic_testing_use_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Karyotype&#x000a0;<sup>11</sup></td><td headers="hd_h_nfia-dis.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/13&#x000a0;<sup>12</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="nfia-dis.TF.1.1"><p class="no_margin">See <a href="/books/NBK542336/#nfia-dis.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="nfia-dis.TF.1.2"><p class="no_margin">See <a href="#nfia-dis.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="nfia-dis.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="nfia-dis.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#nfia-dis.REF.iossifov.2012.285">Iossifov et al [2012]</a>, <a class="bk_pop" href="#nfia-dis.REF.negishi.2015.15007">Negishi et al [2015]</a>, <a class="bk_pop" href="#nfia-dis.REF.revahpoliti.2017.3158">Revah-Politi et al [2017]</a></p></div></dd><dt>5. </dt><dd><div id="nfia-dis.TF.1.5"><p class="no_margin">The number of probands is 13; some probands have other <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members. The total number of individuals reported with <i>NFIA</i>-related disorder is 20 (see <a class="bk_pop" href="#nfia-dis.REF.revahpoliti.2017.3158">Revah-Politi et al [2017]</a>, Table 2).</p></div></dd><dt>6. </dt><dd><div id="nfia-dis.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="nfia-dis.TF.1.7"><p class="no_margin">Intragenic deletions that affect one or multiple exons within NFIA but disrupt no other genes have been identified in five probands [<a class="bk_pop" href="#nfia-dis.REF.mikhail.2011.2386">Mikhail et al 2011</a>, <a class="bk_pop" href="#nfia-dis.REF.rao.2014.65">Rao et al 2014</a>, <a class="bk_pop" href="#nfia-dis.REF.nyboe.2015.109">Nyboe et al 2015</a>, <a class="bk_pop" href="#nfia-dis.REF.bayat.2017.148">Bayat et al 2017</a>, <a class="bk_pop" href="#nfia-dis.REF.hollenbeck.2017.377">Hollenbeck et al 2017</a>].</p></div></dd><dt>8. </dt><dd><div id="nfia-dis.TF.1.8"><p class="no_margin">Gene-targeted methods will detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> up to whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions; however, breakpoints of large deletions and/or <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of adjacent genes may not be determined.</p></div></dd><dt>9. </dt><dd><div id="nfia-dis.TF.1.9"><p class="no_margin">Chromosomal microarray analysis (CMA) using oligonucleotide arrays or SNP arrays. CMA designs in current clinical use typically cover the 1p31.3 region.</p></div></dd><dt>10. </dt><dd><div id="nfia-dis.TF.1.10"><p class="no_margin"><a class="bk_pop" href="#nfia-dis.REF.lu.2007.e80">Lu et al [2007]</a>, <a class="bk_pop" href="#nfia-dis.REF.mikhail.2011.2386">Mikhail et al [2011]</a>, <a class="bk_pop" href="#nfia-dis.REF.rao.2014.65">Rao et al [2014]</a>, <a class="bk_pop" href="#nfia-dis.REF.nyboe.2015.109">Nyboe et al [2015]</a>, <a class="bk_pop" href="#nfia-dis.REF.coci.2016.10">Coci et al [2016]</a>, <a class="bk_pop" href="#nfia-dis.REF.bayat.2017.148">Bayat et al [2017]</a>, <a class="bk_pop" href="#nfia-dis.REF.hollenbeck.2017.377">Hollenbeck et al [2017]</a></p></div></dd><dt>11. </dt><dd><div id="nfia-dis.TF.1.11"><p class="no_margin">Karyotype can detect balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangements that are not detectable through <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis.</p></div></dd><dt>12. </dt><dd><div id="nfia-dis.TF.1.12"><p class="no_margin">Chromosome rearrangements, including translocations and inversions, which disrupt <i>NFIA</i> (in some cases, shown to result in deletions at the breakpoints), have been identified in three probands [<a class="bk_pop" href="#nfia-dis.REF.lu.2007.e80">Lu et al 2007</a>, <a class="bk_pop" href="#nfia-dis.REF.coci.2016.10">Coci et al 2016</a>].</p></div></dd></dl></div></div></div><p>Note: For <i>NFIA</i> somatic variants, see <a href="#nfia-dis.Genetically_Related_Allelic_Dis">Genetically Related Disorders</a>, <b>Cancer and benign tumors</b>.</p></div></div><div id="nfia-dis.Clinical_Characteristics"><h2 id="_nfia-dis_Clinical_Characteristics_">Clinical Characteristics</h2><div id="nfia-dis.Clinical_Description"><h3>Clinical Description</h3><p><i>NFIA</i>-related disorder comprises central nervous system abnormalities (see <a href="#nfia-dis.Suggestive_Findings">Suggestive Findings</a>) with or without urinary tract defects. Additional features include macrocephaly, seizures, developmental delay, <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features (see below), ventriculomegaly, and hypotonia.</p><p><b>Central nervous system (CNS) abnormalities.</b> Abnormalities of the corpus callosum are the most consistent feature of this disorder, present in virtually all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (all but one published individual to date). These abnormalities can include agenesis of the corpus callosum, hypoplasia of the corpus callosum, or other defects (including dysgenesis of the corpus callosum, agenesis of the rostral part of the corpus callosum, or thin corpus callosum). Other CNS phenotypes that may be present include non-progressive ventriculomegaly, hydrocephalus, Chiari type I malformation, and tethered spinal cord. Less common CNS findings include polymicrogyria and decreased periventricular white matter. There appears to be <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> of the CNS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, with no one affected individual presenting with all of the different features listed here.</p><p><b>Seizures</b> are present in approximately half of reported individuals. The types of seizures range from tonic-clonic seizures [<a class="bk_pop" href="#nfia-dis.REF.lu.2007.e80">Lu et al 2007</a>] to pseudo-seizures [<a class="bk_pop" href="#nfia-dis.REF.revahpoliti.2017.3158">Revah-Politi et al 2017</a>] to nonspecific seizure disorders [<a class="bk_pop" href="#nfia-dis.REF.lu.2007.e80">Lu et al 2007</a>, <a class="bk_pop" href="#nfia-dis.REF.revahpoliti.2017.3158">Revah-Politi et al 2017</a>].</p><p><b>Developmental delay,</b> ranging from mild to severe, includes both motor and speech delays. Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals also have <b>hypotonia</b>, which can exacerbate motor delays and feeding issues (particularly in infancy). Despite early delays, most affected individuals are able to walk and use verbal language to communicate. The oldest reported affected individual was a male age 42 years (father of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in <a class="bk_pop" href="#nfia-dis.REF.nyboe.2015.109">Nyboe et al [2015]</a>) who was not reported to have any developmental delays. Of probands with developmental delay, the oldest reported individual was a female age 25 years, who at the time of evaluation was experiencing some cognitive delays and behavioral issues [<a class="bk_pop" href="#nfia-dis.REF.mikhail.2011.2386">Mikhail et al 2011</a>]. Behavioral abnormalities reported in affected individuals include autism [<a class="bk_pop" href="#nfia-dis.REF.iossifov.2012.285">Iossifov et al 2012</a>, <a class="bk_pop" href="#nfia-dis.REF.revahpoliti.2017.3158">Revah-Politi et al 2017</a>] and bipolar disorder / depression [<a class="bk_pop" href="#nfia-dis.REF.mikhail.2011.2386">Mikhail et al 2011</a>, <a class="bk_pop" href="#nfia-dis.REF.revahpoliti.2017.3158">Revah-Politi et al 2017</a>]. Intellectual disability (which may be mild) has also been reported [<a class="bk_pop" href="#nfia-dis.REF.mikhail.2011.2386">Mikhail et al 2011</a>, <a class="bk_pop" href="#nfia-dis.REF.coci.2016.10">Coci et al 2016</a>, <a class="bk_pop" href="#nfia-dis.REF.hollenbeck.2017.377">Hollenbeck et al 2017</a>].</p><p><b>Urinary tract defects</b> described in individuals with <i>NFIA</i>-related disorder most commonly include vesicoureteral reflux and hydronephrosis (which may be unilateral or bilateral); additional phenotypes include pyelonephritis, ureterovesical junction diverticulum, dysplastic kidneys, and renal cysts. Sometimes the defects manifest as recurrent urinary tract infections. Urinary tract defects are present in approximately half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#nfia-dis.REF.revahpoliti.2017.3158">Revah-Politi et al 2017</a>], with reported intrafamilial variation [<a class="bk_pop" href="#nfia-dis.REF.nyboe.2015.109">Nyboe et al 2015</a>, <a class="bk_pop" href="#nfia-dis.REF.revahpoliti.2017.3158">Revah-Politi et al 2017</a>].</p><p><b>Dysmorphic features</b> associated with <i>NFIA</i>-related disorder are typically described as mild and have variable <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. Recurrent features include relative macrocephaly, frontal bossing / prominent forehead, low-set ears, and proximally placed first digits [<a class="bk_pop" href="#nfia-dis.REF.revahpoliti.2017.3158">Revah-Politi et al 2017</a>].</p><p><b>Eye abnormalities</b> have been reported in rare instances and include strabismus divergens in two individuals [<a class="bk_pop" href="#nfia-dis.REF.coci.2016.10">Coci et al 2016</a>], ptosis in two individuals [<a class="bk_pop" href="#nfia-dis.REF.coci.2016.10">Coci et al 2016</a>, <a class="bk_pop" href="#nfia-dis.REF.hollenbeck.2017.377">Hollenbeck et al 2017</a>], and esotropia in one individual [<a class="bk_pop" href="#nfia-dis.REF.hollenbeck.2017.377">Hollenbeck et al 2017</a>].</p><p><b>Dermatologic findings.</b> Cutis marmorata has been reported in one individual with an intragenic <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>NFIA</i> [<a class="bk_pop" href="#nfia-dis.REF.rao.2014.65">Rao et al 2014</a>].</p><p>Note: Cutis marmorata has been described in multiple individuals with deletions that include <i>NFIA</i> and surrounding genes (see <a href="#nfia-dis.Genetically_Related_Allelic_Dis">Genetically Related Disorders</a>), suggesting the existence of another rare <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> associated with NFIA <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>.</p><p><b>Craniosynostosis</b> has been seen in a minority of individuals with <i>NFIA</i> pathogenic variants [<a class="bk_pop" href="#nfia-dis.REF.rao.2014.65">Rao et al 2014</a>, <a class="bk_pop" href="#nfia-dis.REF.nyboe.2015.109">Nyboe et al 2015</a>]. Types of craniosynostosis reported include metopic, lambdoid, and sagittal.</p><p><b>Prognosis.</b> It is unknown if life span in <i>NF1A</i>-related disorder is abnormal. One reported individual is alive at age 42 years [<a class="bk_pop" href="#nfia-dis.REF.nyboe.2015.109">Nyboe et al 2015</a>], demonstrating that survival into adulthood is possible. Since many adults with disabilities have not undergone advanced genetic testing, it is likely that adults with this condition are underrecognized and underreported.</p></div><div id="nfia-dis.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been identified to date, with the exception of individuals who have larger, nonrecurrent 1p31.3 deletions that include <i>NFIA</i> and other, often adjacent, genes (see <a href="#nfia-dis.Genetically_Related_Allelic_Dis">Genetically Related Disorders</a>) [<a class="bk_pop" href="#nfia-dis.REF.lu.2007.e80">Lu et al 2007</a>, <a class="bk_pop" href="#nfia-dis.REF.koehler.2010.463">Koehler et al 2010</a>, <a class="bk_pop" href="#nfia-dis.REF.chen.2011.345">Chen et al 2011</a>, <a class="bk_pop" href="#nfia-dis.REF.ji.2014.267">Ji et al 2014</a>, <a class="bk_pop" href="#nfia-dis.REF.labonne.2016.24">Labonne et al 2016</a>].</p></div><div id="nfia-dis.Nomenclature"><h3>Nomenclature</h3><p>Early reports that identified deletions affecting <i>NFIA</i> referred to the phenotypic presentation as "<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 1p32-p31 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a>" or "chromosome 1p31 deletion." The identification of intragenic deletions and single-nucleotide variants within <i>NFIA</i> that lead to a similar phenotypic presentation have demonstrated that loss of function of <i>NFIA</i> is responsible for most of the phenotypes associated with the 1p31 deletion.</p><p><i>NFIA</i>-related disorder is referred to as "brain malformations with or without urinary tract defects" (BRMUTD) in OMIM (<a href="https://www.omim.org/entry/613735" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613735</a>).</p></div><div id="nfia-dis.Prevalence"><h3>Prevalence</h3><p><i>NFIA</i>-related disorder is rare, having been described in only 13 families representing 20 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div></div><div id="nfia-dis.Genetically_Related_Allelic_Dis"><h2 id="_nfia-dis_Genetically_Related_Allelic_Dis_">Genetically Related (Allelic) Disorders</h2><p><b>Chromosome 1p32-p31 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a>.</b> Individuals with larger deletions of the 1p32-p31 region that involve <i>NFIA</i> and other, often adjacent, genes have been reported (see, e.g., <a class="bk_pop" href="#nfia-dis.REF.chen.2011.345">Chen et al [2011]</a>, <a class="bk_pop" href="#nfia-dis.REF.ji.2014.267">Ji et al [2014]</a>). Additional reported features not seen in those with <i>NFIA</i>-related disorder may include <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects [<a class="bk_pop" href="#nfia-dis.REF.ji.2014.267">Ji et al 2014</a>], ambiguous external genitalia [<a class="bk_pop" href="#nfia-dis.REF.chen.2011.345">Chen et al 2011</a>], attention-deficit/hyperactivity disorder [<a class="bk_pop" href="#nfia-dis.REF.lu.2007.e80">Lu et al 2007</a>, <a class="bk_pop" href="#nfia-dis.REF.labonne.2016.24">Labonne et al 2016</a>], congenital hip dysplasia [<a class="bk_pop" href="#nfia-dis.REF.lu.2007.e80">Lu et al 2007</a>], short limbs [<a class="bk_pop" href="#nfia-dis.REF.lu.2007.e80">Lu et al 2007</a>], cutis marmorata, and syringomyelia [<a class="bk_pop" href="#nfia-dis.REF.campbell.2002.289">Campbell et al 2002</a>, <a class="bk_pop" href="#nfia-dis.REF.lu.2007.e80">Lu et al 2007</a>]. However, given the many overlapping phenotypes between individuals with the 1p32-p31 deletion syndrome and those with <i>NFIA</i> pathogenic variants, <i>NFIA</i> has been proposed to be the critical <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> within this deletion syndrome region [<a class="bk_pop" href="#nfia-dis.REF.revahpoliti.2017.3158">Revah-Politi et al 2017</a>].</p><p><b>Cancer and benign tumors.</b> Sporadic tumors occurring as single tumors in the absence of any other findings of <i>NFIA</i>-related disorder may harbor somatic nucleotide variants in <i>NFIA</i> that are not present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>. Per the <a href="https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=NFIA" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COSMIC</a> database (last accessed 2-28-19), 171 different tumor samples (including many different tumor types) have been reported to have pathogenic variants in <i>NFIA</i>. However, given the limited number of individuals with <i>NFIA</i>-related disorder, the natural history of this disorder is still evolving. An increased risk for cancer predisposition has not been observed in individuals with <i>NFIA</i>-related disorder but cannot be excluded.</p></div><div id="nfia-dis.Differential_Diagnosis"><h2 id="_nfia-dis_Differential_Diagnosis_">Differential Diagnosis</h2><div id="nfia-dis.T.disorders_to_consider_in_the" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of <i>NFIA</i>-Related Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK542336/table/nfia-dis.T.disorders_to_consider_in_the/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nfia-dis.T.disorders_to_consider_in_the_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_1" style="text-align:left;vertical-align:middle;">Differential<br />Diagnosis<br />Disorder</th><th id="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features of the Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_4" id="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/<i>NFIA</i>-related disorder</th><th headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_4" id="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from <i>NFIA</i>-related disorder</th></tr></thead><tbody><tr><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sotos/">Sotos syndrome</a>&#x000a0;<sup>1</sup></td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NSD1</i></td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_4 hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Macrocephaly</div></li><li class="half_rhythm"><div>Ventriculomegaly</div></li><li class="half_rhythm"><div>DD</div></li><li class="half_rhythm"><div>Brain malformations incl partial-to-complete agenesis of corpus callosum</div></li></ul>
</td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_4 hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>No urinary tract defects</div></li><li class="half_rhythm"><div>Sotos syndrome typically includes distinctive facial appearance &#x00026; overgrowth.</div></li></ul>
</td></tr><tr><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Acquired macrocephaly w/impaired intellectual development<br />(OMIM <a href="https://omim.org/entry/618286" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">618286</a>)</td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NFIB</i></td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_4 hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Macrocephaly</div></li><li class="half_rhythm"><div>DD</div></li><li class="half_rhythm"><div>Minor <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features</div></li><li class="half_rhythm"><div>Brain malformations incl dysgenesis of corpus callosum</div></li><li class="half_rhythm"><div>Neurodevelopmental phenotypes</div></li></ul>
</td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_4 hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No urinary tract defects (in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported to date)</td></tr><tr><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Malan syndrome&#x000a0;<sup>2</sup><br />(OMIM <a href="https://omim.org/entry/614753" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614753</a>)</td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NFIX</i></td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_4 hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Macrocephaly</div></li><li class="half_rhythm"><div>Ventriculomegaly</div></li><li class="half_rhythm"><div>DD</div></li><li class="half_rhythm"><div>Brain malformations incl hypoplasia of corpus callosum</div></li></ul>
</td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_4 hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Individuals w/Malan syndrome generally have an overgrowth <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</td></tr><tr><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/joubert/">Joubert syndrome 9</a></td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CC2D2A</i></td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_4 hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Ventriculomegaly w/seizures in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</div></li><li class="half_rhythm"><div>Agenesis of corpus callosum</div></li><li class="half_rhythm"><div>Hydrocephalus</div></li><li class="half_rhythm"><div>Renal disease</div></li></ul>
</td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_4 hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Typically more severe than <i>NFIA</i>-related disorder</div></li><li class="half_rhythm"><div>Characteristic MRI findings ("molar tooth sign")</div></li><li class="half_rhythm"><div>Eye abnormalities</div></li></ul>
</td></tr><tr><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Stromme syndrome<br />(OMIM <a href="https://www.omim.org/entry/243605" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">243605</a>)</td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CENPF</i></td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_4 hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hydrocephalus</div></li><li class="half_rhythm"><div>Agenesis of corpus callosum</div></li><li class="half_rhythm"><div>Renal abnormalities incl hydronephrosis</div></li></ul>
</td><td headers="hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_1_4 hd_h_nfia-dis.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Typically more severe than <i>NFIA</i>-related disorder</div></li><li class="half_rhythm"><div>Intestinal atresia</div></li><li class="half_rhythm"><div>Ocular abnormalities</div></li><li class="half_rhythm"><div>Microcephaly</div></li><li class="half_rhythm"><div>Cardiac involvement</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; DD = developmental delay; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt>1. </dt><dd><div id="nfia-dis.TF.2.1"><p class="no_margin">Because Sotos syndrome and Malan syndrome have overlapping features, Sotos syndrome is sometimes referred to as Sotos syndrome 1.</p></div></dd><dt>2. </dt><dd><div id="nfia-dis.TF.2.2"><p class="no_margin">Malan syndrome is also referred to as Sotos syndrome 2.</p></div></dd></dl></div></div></div></div><div id="nfia-dis.Management"><h2 id="_nfia-dis_Management_">Management</h2><div id="nfia-dis.Evaluations_Following_Initial_D"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>NFIA</i>-related disorder, the evaluations summarized in <a class="figpopup" href="/books/NBK542336/table/nfia-dis.T.recommended_evaluations_follo/?report=objectonly" target="object" rid-figpopup="fignfiadisTrecommendedevaluationsfollo" rid-ob="figobnfiadisTrecommendedevaluationsfollo">Table 3</a> (if not performed as part of the evaluation that led to diagnosis) are recommended.</p><div id="nfia-dis.T.recommended_evaluations_follo" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with <i>NFIA</i>-Related Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK542336/table/nfia-dis.T.recommended_evaluations_follo/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nfia-dis.T.recommended_evaluations_follo_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Brain MRI</td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for brain anomalies, incl Chiari type I malformation</td></tr><tr><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Spinal imaging&#x000a0;<sup>1</sup></td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for tethered cord</td></tr><tr><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">EEG</td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If seizures are suspected; referral to neurologist if EEG is abnormal or if strong suspicion of seizures</td></tr><tr><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Development</b></td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment</td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To incl motor, adaptive, cognitive, &#x00026; speech/language evaluation</td></tr><tr><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_3" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Evaluation for early intervention / special education</td></tr><tr><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Psychiatric/</b><br /><b>Behavioral</b></td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neuropsychiatric evaluation</td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For individuals age &#x0003e;12 mos: screen for behavior concerns incl sleep disturbances, ADHD, anxiety, &#x00026;/or traits suggestive of ASD.</td></tr><tr><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal/</b><br /><b>Feeding</b></td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider feeding evaluation for feeding problems related to hypotonia.</td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 reported individual w/<i>NFIA-</i>related disorder was able to tolerate only a soft diet at age 5 yrs but could eat other foods by age 8 yrs.&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Genitourinary</b></td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Renal ultrasound</td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To detect renal anomalies</td></tr><tr><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Consider voiding cystourethrogram.</td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In those w/suggestive renal ultrasound findings or w/urinary tract infections</td></tr><tr><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation</td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For possible strabismus</td></tr><tr><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Craniofacial</b></td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider craniofacial 3D-computed tomographic scanning in those w/abnormal head shape.</td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to craniofacial team if concern for craniosynostosis.</td></tr><tr><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To incl <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a></td></tr><tr><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Family support/resources</td><td headers="hd_h_nfia-dis.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Use of community or online resources such as Parent to Parent</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">ADHD = attention-deficit/hyperactivity disorder; ASD = autism spectrum disorder</p></div></dd><dt>1. </dt><dd><div id="nfia-dis.TF.3.1"><p class="no_margin">The choice of imaging depends on the age of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. In infants &#x0003c;3 months of age, spinal ultrasound may be used. In those &#x0003e;3 months of age, typically spinal MRI is required.</p></div></dd><dt>2. </dt><dd><div id="nfia-dis.TF.3.2"><p class="no_margin"><a class="bk_pop" href="#nfia-dis.REF.shanske.2004.29">Shanske et al [2004]</a>, <a class="bk_pop" href="#nfia-dis.REF.lu.2007.e80">Lu et al [2007]</a></p></div></dd></dl></div></div></div></div><div id="nfia-dis.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><div id="nfia-dis.T.treatment_of_manifestations_i" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with NFIA-Related Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK542336/table/nfia-dis.T.treatment_of_manifestations_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nfia-dis.T.treatment_of_manifestations_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/Concern</th><th id="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Seizures</b></td><td headers="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment w/AEDs by experienced neurologist</td><td headers="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Many different AEDs may be effective; no one AED has been demonstrated effective specifically for this disorder.</td></tr><tr><td headers="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Tethered spinal cord</b></td><td headers="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per neurosurgeon</td><td headers="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Developmental delay / intellectual disability</b></td><td headers="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a href="#nfia-dis.Developmental_Delay__Intellectu">Developmental Delay / Intellectual Disability Management Issues</a>.</td><td headers="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Recurrent urinary tract infections &#x00026;/or hydronephrosis</b></td><td headers="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per urologist</td><td headers="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Strabismus</b></td><td headers="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per ophthalmologist</td><td headers="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Craniosynostosis</b></td><td headers="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment</td><td headers="hd_h_nfia-dis.T.treatment_of_manifestations_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to a craniofacial team w/experience in treating craniosynostosis.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AEDs = antiepileptic drugs</p></div></dd></dl></div></div></div><div id="nfia-dis.Developmental_Delay__Intellectu"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States (US); standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years</b></p><ul><li class="half_rhythm"><div>In the US, an IEP based on the individual's level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</div></li><li class="half_rhythm"><div>Discussion about transition plans including financial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</div></li></ul><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="nfia-dis.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction.</b> Physical therapy is recommended to maximize mobility.</p><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral motor dysfunction.</b> If feeding difficulty is present, particularly in infancy, referral to an occupational or speech therapist for evaluation and treatment, including feeding therapy, is recommended. At least one individual with <i>NFIA-</i>related disorder has been reported with a history of feeding issues [<a class="bk_pop" href="#nfia-dis.REF.shanske.2004.29">Shanske et al 2004</a>, <a class="bk_pop" href="#nfia-dis.REF.lu.2007.e80">Lu et al 2007</a>].</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) for individuals who have expressive language difficulties.</p></div><div id="nfia-dis.SocialBehavioral_Concerns"><h4>Social/Behavioral Concerns</h4><p>Children may qualify for and benefit from interventions used in treatment of autism spectrum disorder, including applied behavior analysis (ABA). ABA therapy is targeted to the individual child's behavioral, social, and adaptive strengths and weaknesses and is typically performed one on one with a board-certified behavior analyst.</p><p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavior management strategies or providing prescription medications, such as medication used to treat ADHD, when necessary.</p></div></div><div id="nfia-dis.Surveillance"><h3>Surveillance</h3><p>Following initial evaluation, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals should be followed by the appropriate specialists (e.g., neurologist, urologist, and/or clinical geneticist) as needed based on their particular features.</p></div><div id="nfia-dis.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to clarify the genetic status of apparently asymptomatic older and younger at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the genetic alteration identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in order to identify as early as possible those who would benefit from prompt initiation of treatment.</p><p>See <a href="#nfia-dis.Related_Genetic_Counseling_Issu">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="nfia-dis.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="nfia-dis.Genetic_Counseling"><h2 id="_nfia-dis_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="nfia-dis.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>NFIA</i>-related disorder is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="nfia-dis.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The majority of individuals diagnosed with <i>NFIA</i>-related disorder have the disorder as a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> genetic alteration.</div></li><li class="half_rhythm"><div>Approximately 20%-25% of reported individuals inherited an <i>NFIA</i>-related disorder alteration from an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of an individual with <i>NFIA</i>-related disorder include genetic/<a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing capable of detecting the genetic alteration identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li><li class="half_rhythm"><div>If the genetic alteration identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in either parent, the most likely explanation is that the genetic alteration is <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> in the proband. Another possible explanation is parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> (germline mosaicism has not been reported to date).</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has the genetic alteration identified in the proband, the risk to the sibs is 50%. However, the disorder is known to have <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a>; i.e., a sib who inherits the same genetic alteration may not have the same manifestation of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> as the proband. Intrafamilial variation of the phenotype for the same genetic variant has been reported [<a class="bk_pop" href="#nfia-dis.REF.nyboe.2015.109">Nyboe et al 2015</a>, <a class="bk_pop" href="#nfia-dis.REF.coci.2016.10">Coci et al 2016</a>, <a class="bk_pop" href="#nfia-dis.REF.hollenbeck.2017.377">Hollenbeck et al 2017</a>, <a class="bk_pop" href="#nfia-dis.REF.revahpoliti.2017.3158">Revah-Politi et al 2017</a>].</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a>, <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs depends on the specific structural variant.</div></li><li class="half_rhythm"><div>If the genetic alteration identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is slightly greater than that of the general population because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. Parental germline mosaicism for <i>NFIA</i> genetic alterations has not been reported in the literature thus far.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Each child of an individual with an <i>NFIA</i>-related disorder has a 50% chance of inheriting the genetic alteration.</div></li><li class="half_rhythm"><div>Risk to offspring of an individual with a <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> depends on the specific structural variant.</div></li></ul><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the genetic alteration identified in the proband, his or her family members may be at risk.</p></div><div id="nfia-dis.Related_Genetic_Counseling_Issu"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#nfia-dis.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to the parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child.</div></li></ul></div><div id="nfia-dis.Prenatal_Testing_and_Preimplant"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the causative 1p31.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, <i>NFIA</i> intragenic <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, or <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p><b>Ultrasound examination.</b> Some features of <i>NFIA</i>-related disorder may be identifiable on prenatal ultrasound examination; these include agenesis/hypoplasia of the corpus callosum, ventriculomegaly, and macrocephaly [<a class="bk_pop" href="#nfia-dis.REF.negishi.2015.15007">Negishi et al 2015</a>, <a class="bk_pop" href="#nfia-dis.REF.revahpoliti.2017.3158">Revah-Politi et al 2017</a>]. Poor fetal movement has been described in one case [<a class="bk_pop" href="#nfia-dis.REF.shanske.2004.29">Shanske et al 2004</a>, <a class="bk_pop" href="#nfia-dis.REF.lu.2007.e80">Lu et al 2007</a>].</p></div></div><div id="nfia-dis.Resources"><h2 id="_nfia-dis_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><p>No specific resources for <i>NFIA</i>-Related Disorder have been identified by <i>GeneReviews</i> staff.</p></div><div id="nfia-dis.Molecular_Genetics"><h2 id="_nfia-dis_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="nfia-dis.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>NFIA-Related Disorder: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK542336/table/nfia-dis.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nfia-dis.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_nfia-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_nfia-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_nfia-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_nfia-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_nfia-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_nfia-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4774" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>NFIA</i></a></td><td headers="hd_b_nfia-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4774" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1p31<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_nfia-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q12857" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Nuclear factor 1 A-type</a></td><td headers="hd_b_nfia-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=NFIA" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NFIA</a></td><td headers="hd_b_nfia-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NFIA[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NFIA</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="nfia-dis.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="nfia-dis.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for NFIA-Related Disorder (<a href="/omim/600727,613735" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK542336/table/nfia-dis.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nfia-dis.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600727" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600727</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NUCLEAR FACTOR I/A; NFIA</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613735" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613735</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>NFIA</i> encodes a 554-amino acid protein from a 1.99-kb transcript with 12 exons (based on canonic transcript <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001145512.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001145512.1</a>; also <a href="http://www.ensembl.org/id/ENST00000371189.8" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ENST00000371189.8</a>).</p><p><b><i>NFIA</i>-specific laboratory technical considerations.</b> At least four <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> are produced by alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a>. The numbering of pathogenic variants may differ in the literature and in <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>/mutation databases. <a class="figpopup" href="/books/NBK542336/table/nfia-dis.T.nfia_reference_sequences/?report=objectonly" target="object" rid-figpopup="fignfiadisTnfiareferencesequences" rid-ob="figobnfiadisTnfiareferencesequences">Table 5</a> may be useful for at least some of the alternative transcripts.</p><div id="nfia-dis.T.nfia_reference_sequences" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p><i>NFIA</i> Reference Sequences</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK542336/table/nfia-dis.T.nfia_reference_sequences/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nfia-dis.T.nfia_reference_sequences_lrgtbl__"><table><thead><tr><th id="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ensemble Transcript</th><th id="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NCBI transcript</th><th id="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein</th><th id="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comments</th></tr></thead><tbody><tr><td headers="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="http://www.ensembl.org/id/ENST00000403491.7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ENST00000403491<wbr style="display:inline-block"></wbr>​.7</a></td><td headers="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001134673.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001134673<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">509</td><td headers="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Longest transcript</td></tr><tr><td headers="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="http://uswest.ensembl.org/Homo_sapiens/Transcript/Summary?db=core;g=ENSG00000162599;r=1:61081862-61455562;t=ENST00000407417" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ENST00000407417<wbr style="display:inline-block"></wbr>​.7</a></td><td headers="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001145511.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001145511<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">501</td><td headers="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Used by ClinVar</td></tr><tr><td headers="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="http://www.ensembl.org/id/ENST00000371189.8" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ENST00000371189<wbr style="display:inline-block"></wbr>​.8</a></td><td headers="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001145512.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001145512<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">554</td><td headers="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Cited as canonic by Ensembl</td></tr><tr><td headers="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="http://www.ensembl.org/id/ENST00000371187.7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ENST00000371187<wbr style="display:inline-block"></wbr>​.7</a></td><td headers="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005595.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005595<wbr style="display:inline-block"></wbr>​.4</a></td><td headers="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">498</td><td headers="hd_h_nfia-dis.T.nfia_reference_sequences_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Used by HGMD &#x00026; ClinVar</td></tr></tbody></table></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>NFIA</i> encodes a <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a> belonging to the nuclear factor I family of dimeric DNA-binding proteins, and includes an N-terminal DNA-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> as well as C-terminal transactivation and repression domains.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Haploinsufficiency of the <i>NFIA</i> protein causes the phenotypes associated with <i>NFIA-</i>related disorder. Animal studies have shown that <i>NFIA</i> is essential for normal development of the central nervous system and that it is required in a dose-sensitive manner for ureteral and renal development [<a class="bk_pop" href="#nfia-dis.REF.lu.2007.e80">Lu et al 2007</a>]. Reduced dosage of <i>NFIA</i> may disrupt transcriptional networks important to the development of these organ systems.</p><div id="nfia-dis.Cancer_and_Benign_Tumors"><h3>Cancer and Benign Tumors</h3><p>Numerous <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> tumors (e.g., glioblastoma) occurring as single tumors in the absence of any other findings of <i>NFIA</i>-related disorder may harbor somatic <i>NFIA</i> nucleotide variants and/or show changes in <i>NFIA</i> expression that are not present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>; thus, predisposition to these tumors is not known to be heritable.</p></div></div><div id="nfia-dis.References"><h2 id="_nfia-dis_References_">References</h2><div id="nfia-dis.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="nfia-dis.REF.bayat.2017.148">Bayat A, Kirchhoff M, Madsen CG, Roos L, Kreiborg S. Familial craniofacial abnormality and polymicrogyria associated with a microdeletion affecting the NFIA gene. <span><span class="ref-journal">Clin Dysmorphol. </span>2017;<span class="ref-vol">26</span>:148–53.</span> [<a href="/pubmed/28452798" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28452798</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nfia-dis.REF.campbell.2002.289">Campbell CG, Wang H, Hunter GW. Interstitial microdeletion of chromosome 1p in two siblings. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">111</span>:289–94.</span> [<a href="/pubmed/12210325" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12210325</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nfia-dis.REF.chen.2011.345">Chen CP, Su YN, Chen YY, Chern SR, Liu YP, Wu PC, Lee CC, Chen YT, Wang W. Chromosome 1p32-p31 deletion syndrome: prenatal diagnosis by array comparative genomic hybridization using uncultured amniocytes and association with NFIA haploinsufficiency, ventriculomegaly, corpus callosum hypogenesis, abnormal external genitalia, and intrauterine growth restriction. <span><span class="ref-journal">Taiwan J Obstet Gynecol. </span>2011;<span class="ref-vol">50</span>:345–52.</span> [<a href="/pubmed/22030051" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22030051</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nfia-dis.REF.coci.2016.10">Coci EG, Koehler U, Liehr T, Stelzner A, Fink C, Langen H, Riedel J. CANPMR syndrome and chromosome 1p32-p31 deletion syndrome coexist in two related individuals affected by simultaneous haplo-insufficiency of CAMTA1 and NIFA genes. <span><span class="ref-journal">Mol Cytogenet. </span>2016;<span class="ref-vol">9</span>:10.</span> [<a href="/pmc/articles/PMC4741010/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4741010</span></a>] [<a href="/pubmed/26848311" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26848311</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nfia-dis.REF.hollenbeck.2017.377">Hollenbeck D, Williams CL, Drazba K, Descartes M, Korf BR, Rutledge SL, Lose EJ, Robin NH, Carroll AJ, Mikhail FM. Clinical relevance of small copy-number variants in chromosomal microarray clinical testing. <span><span class="ref-journal">Genet Med. </span>2017;<span class="ref-vol">19</span>:377–85.</span> [<a href="/pubmed/27632688" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27632688</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nfia-dis.REF.iossifov.2012.285">Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J, Yamrom B, Lee YH, Narzisi G, Leotta A, Kendall J, Grabowska E, Ma B, Marks S, Rodgers L, Stepansky A, Troge J, Andrews P, Bekritsky M, Pradhan K, Ghiban E, Kramer M, Parla J, Demeter R, Fulton LL, Fulton RS, Magrini VJ, Ye K, Darnell JC, Darnell RB, Mardis ER, Wilson RK, Schatz MC, McCombie WR, Wigler M. De novo gene disruptions in children on the autistic spectrum. <span><span class="ref-journal">Neuron. </span>2012;<span class="ref-vol">74</span>:285–99.</span> [<a href="/pmc/articles/PMC3619976/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3619976</span></a>] [<a href="/pubmed/22542183" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22542183</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nfia-dis.REF.ji.2014.267">Ji J, Salamon N, Quintero-Rivera F. Microdeletion of 1p32-p31 involving NFIA in a patient with hypoplastic corpus callosum, ventriculomegaly, seizures and urinary tract defects. <span><span class="ref-journal">Eur J Med Genet. </span>2014;<span class="ref-vol">57</span>:267–8.</span> [<a href="/pubmed/24657733" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24657733</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nfia-dis.REF.koehler.2010.463">Koehler U, Holinski-Feder E, Ertl-Wagner B, Kunz J, von Moers A, von Voss H, Schell-Apacik C. A novel 1p31.3p32.2 deletion involving the NFIA gene detected by array CGH in a patient with macrocephaly and hypoplasia of the corpus callosum. <span><span class="ref-journal">Eur J Pediatr. </span>2010;<span class="ref-vol">169</span>:463–8.</span> [<a href="/pubmed/19763616" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19763616</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nfia-dis.REF.labonne.2016.24">Labonne JD, Shen Y, Kong IK, Diamond MP, Layman LC, Kim HG. Comparative deletion mapping at 1p31.3-p32.2 implies NFIA responsible for intellectual disability coupled with macrocephaly and the presence of several other genes for syndromic intellectual disability. <span><span class="ref-journal">Mol Cytogenet. </span>2016;<span class="ref-vol">9</span>:24.</span> [<a href="/pmc/articles/PMC4797196/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4797196</span></a>] [<a href="/pubmed/26997977" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26997977</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nfia-dis.REF.lu.2007.e80">Lu W, Quintero-Rivera F, Fan Y, Alkuraya FS, Donovan DJ, Xi Q, Turbe-Doan A, Li QG, Campbell CG, Shanske AL, Sherr EH, Ahmad A, Peters R, Rilliet B, Parvex P, Bassuk AG, Harris DJ, Ferguson H, Kelly C, Walsh CA, Gronostajski RM, Devriendt K, Higgins A, Ligon AH, Quade BJ, Morton CC, Gusella JF, Maas RL. NFIA haploinsufficiency is associated with a CNS malformation syndrome and urinary tract defects. <span><span class="ref-journal">PLoS Genet. </span>2007;<span class="ref-vol">3</span>:e80.</span> [<a href="/pmc/articles/PMC1877820/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1877820</span></a>] [<a href="/pubmed/17530927" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17530927</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nfia-dis.REF.mikhail.2011.2386">Mikhail FM, Lose EJ, Robin NH, Descartes MD, Rutledge KD, Rutledge SL, Korf BR, Carroll AJ. Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:2386–96.</span> [<a href="/pubmed/22031302" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22031302</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nfia-dis.REF.negishi.2015.15007">Negishi Y, Miya F, Hattori A, Mizuno K, Hori I, Ando N, Okamoto N, Kato M, Tsunoda T, Yamasaki M, Kanemura Y, Kosaki K, Saitoh S. Truncating mutation in NFIA causes brain malformation and urinary tract defects. <span><span class="ref-journal">Hum Genome Var. </span>2015;<span class="ref-vol">2</span>:15007.</span> [<a href="/pmc/articles/PMC4785547/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4785547</span></a>] [<a href="/pubmed/27081522" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27081522</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nfia-dis.REF.nyboe.2015.109">Nyboe D, Kreiborg S, Kirchhoff M, Hove HB. Familial craniosynostosis associated with a microdeletion involving the NFIA gene. <span><span class="ref-journal">Clin Dysmorphol. </span>2015;<span class="ref-vol">24</span>:109–12.</span> [<a href="/pubmed/25714559" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25714559</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nfia-dis.REF.rao.2014.65">Rao A, O'Donnell S, Bain N, Meldrum C, Shorter D, Goel H. An intragenic deletion of the NFIA gene in a patient with a hypoplastic corpus callosum, craniofacial abnormalities and urinary tract defects. <span><span class="ref-journal">Eur J Med Genet. </span>2014;<span class="ref-vol">57</span>:65–70.</span> [<a href="/pubmed/24462883" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24462883</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nfia-dis.REF.revahpoliti.2017.3158">Revah-Politi A, Ganapathi M, Bier L, Cho MT, Goldstein DB, Hemati P, Iglesias A, Juusola J, Pappas J, Petrovski S, Wilson AL, Aggarwal VS, Anyane-Yeboa K. Loss-of-function variants in NFIA provide further support that NFIA is a critical gene in 1p32-p31 deletion syndrome: a four patient series. <span><span class="ref-journal">Am J Med Genet A. </span>2017;<span class="ref-vol">173</span>:3158–64.</span> [<a href="/pubmed/28941020" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28941020</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nfia-dis.REF.shanske.2004.29">Shanske AL, Edelmann L, Kardon NB, Gosset P, Levy B. Detection of an interstitial deletion of 2q21-22 by high resolution comparative genomic hybridization in a child with multiple congenital anomalies and an apparent balanced translocation. <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">131</span>:29–35.</span> [<a href="/pubmed/15368480" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15368480</span></a>]</div></li></ul></div></div><div id="nfia-dis.Chapter_Notes"><h2 id="_nfia-dis_Chapter_Notes_">Chapter Notes</h2><div id="nfia-dis.Author_Notes"><h3>Author Notes</h3><p>Fabiola Quintero-Rivera, MD <a href="http://pathology.ucla.edu/laboratory-genetics-and-genomics" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">web page</a></p></div><div id="nfia-dis.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>13 June 2019 (ma) Review posted live</div></li><li class="half_rhythm"><div>2 March 2018 (fqr) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK542336</span><span class="label">PMID: <a href="/pubmed/31194316" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31194316</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/norrie/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ngly1-cddg/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK542336&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK542336/?report=reader">PubReader</a></li><li><a href="/books/NBK542336/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK542336" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK542336" style="display:none" title="Cite this Page"><div class="bk_tt">Senaratne TN, Quintero-Rivera F. NFIA-Related Disorder. 2019 Jun 13. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK542336/pdf/Bookshelf_NBK542336.pdf">PDF version of this page</a> (458K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#nfia-dis.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#nfia-dis.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#nfia-dis.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#nfia-dis.Genetically_Related_Allelic_Dis" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#nfia-dis.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#nfia-dis.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#nfia-dis.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#nfia-dis.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#nfia-dis.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#nfia-dis.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#nfia-dis.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4774[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">NFIA</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4784354" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4784354" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4784354" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4784354" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28941020" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Loss-of-function variants in NFIA provide further support that NFIA is a critical gene in 1p32-p31 deletion syndrome: A four patient series.</a><span class="source">[Am J Med Genet A. 2017]</span><div class="brieflinkpop offscreen_noflow">Loss-of-function variants in NFIA provide further support that NFIA is a critical gene in 1p32-p31 deletion syndrome: A four patient series.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Revah-Politi A, Ganapathi M, Bier L, Cho MT, Goldstein DB, Hemati P, Iglesias A, Juusola J, Pappas J, Petrovski S, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2017 Dec; 173(12):3158-3164. Epub 2017 Sep 22.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24462883" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">An intragenic deletion of the NFIA gene in a patient with a hypoplastic corpus callosum, craniofacial abnormalities and urinary tract defects.</a><span class="source">[Eur J Med Genet. 2014]</span><div class="brieflinkpop offscreen_noflow">An intragenic deletion of the NFIA gene in a patient with a hypoplastic corpus callosum, craniofacial abnormalities and urinary tract defects.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Rao A, O'Donnell S, Bain N, Meldrum C, Shorter D, Goel H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Med Genet. 2014 Feb; 57(2-3):65-70. Epub 2014 Jan 22.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/17530927" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">NFIA haploinsufficiency is associated with a CNS malformation syndrome and urinary tract defects.</a><span class="source">[PLoS Genet. 2007]</span><div class="brieflinkpop offscreen_noflow">NFIA haploinsufficiency is associated with a CNS malformation syndrome and urinary tract defects.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lu W, Quintero-Rivera F, Fan Y, Alkuraya FS, Donovan DJ, Xi Q, Turbe-Doan A, Li QG, Campbell CG, Shanske AL, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">PLoS Genet. 2007 May 25; 3(5):e80. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29023086" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SATB2-</i>Associated Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SATB2-</i>Associated Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Zarate YA, Kaylor J, Fish J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27336128" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">FOXP2-</i>Related Speech and Language Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">FOXP2-</i>Related Speech and Language Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Morgan A, Fisher SE, Scheffer I, Hildebrand M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=31194316" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=31194316" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040d9439a66ee2ba5deae8">NFIA-Related Disorder - GeneReviews®</a><div class="ralinkpop offscreen_noflow">NFIA-Related Disorder - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:32:04-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B3BEAE03F8BD1000000000764027F&amp;ncbi_session=CE8B3BEAE040D931_1892SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK542336%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK542336&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK542336/&amp;ncbi_pagename=NFIA-Related Disorder - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B3BEAE040D931_1892SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>